Revenues: | |
Royalties | |
Other | |
Revenues, Total | |
Costs and expenses: | |
Research and development | 1.01M |
General and administrative | 676.93K |
Acquired In-Process R&D | |
Costs and Expenses, Total | 1.69M |
Interest expense | |
Other income (expense) | |
Net Loss | -1.69M |
Dividends on Series A convertible preferred stock | |
Net loss attributable to common shareholders | |
Net loss per share (basic and diluted) | -0.03 |
Weighted average number of common shares outstanding (basic and diluted) |